FDA approves the first targeted therapy to treat a rare mutation in patients with gastrointestinal stromal tumors

Alternative Medicine
FDAThe U.S. Food and Drug Administration approved Ayvakit (avapritinib) for the treatment of adults with unresectable (unable to be removed with surgery) or metastatic (when cancer cells spread to other parts of the body) gastrointestinal stromal tumor (GIST) – a type of tumor that occurs in the gastrointestinal tract,

Leave a Reply

Your email address will not be published. Required fields are marked *